Liver Disease News and Research

RSS

The liver is one of the largest solid organs of the body. It is located in the upper right part of the abdomen. Most of the organ lies under cover of the rib cage.

Childhood heart health predicts lifelong well-being, study finds

Optimal heart health from birth through adolescence, as measured by a combination of metrics, leads to long-lasting cardiovascular and overall physical, cognitive and mental health, according to the systematic review published in the Journal of the American Heart Association.

16 Jul 2025

UK Biobank completes world's largest whole-body imaging project

In a remarkable achievement that is already impacting how we detect and diagnose disease, UK Biobank has completed the world's largest whole body imaging project, scanning the brains, hearts, abdomens, blood vessels, bones and joints of 100,000 volunteers.

16 Jul 2025

Early-career physician-scientists receive major support from Damon Runyon Cancer Research Foundation

The Damon Runyon Cancer Research Foundation has named five new Damon Runyon Clinical Investigators.

14 Jul 2025

New imaging technique reveals mitochondrial activity inside live animals

In this study, researcher developed a new imaging approach that combines two powerful techniques to solve this problem. First, a special type of microscope called a two-photon microscope is used, which can look deep into live tissues with minimal damage.

14 Jul 2025

Exploring the roles of orphan nuclear receptors in MASLD pathogenesis

Metabolic dysfunction-associated steatotic liver disease (MASLD), affecting approximately 30% of the global population, represents a spectrum of liver disorders ranging from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and cirrhosis.

12 Jul 2025

Sticky cell coating boosts liver repair without the need for transplants

A new process could help to treat liver disease without needing an organ transplant, a new study reveals.

10 Jul 2025

Short-term exercise improves liver health by modulating amino acid metabolism

Metabolic-associated steatohepatitis (MASH) is an advanced and progressive liver disease that potentially causes cirrhosis and hepatocellular carcinoma.

10 Jul 2025

Aspartame triggers genetic changes tied to glioblastoma severity

Study shows aspartame affects gut microbiome and gene expression in glioblastoma, highlighting potential links to cancer progression and treatment strategies.

8 Jul 2025

Early-onset gastrointestinal cancer rates rising across the globe

A new paper in BJS, published by Oxford University Press, indicates that early-onset gastrointestinal cancer rates are rising dramatically across the globe.

8 Jul 2025

Poor lifestyle habits nearly double your chance of developing AFib

A large Framingham Heart Study analysis found that adults with poor cardiovascular health scores on the Life’s Essential 8 were nearly twice as likely to develop atrial fibrillation as those with ideal scores. Maintaining healthy lifestyle habits, especially optimal BMI, blood pressure, and glucose, may help reduce AF risk.

2 Jul 2025

New point-of-care device shows promise for accurate bilirubin testing

This pilot study evaluates a newly developed point-of-care (PoC) device designed to measure bilirubin levels in human blood serum using a microfluidic cartridge and optoelectronic sensing module.

2 Jul 2025

Improving fatty liver diagnosis through AI analysis of standard chest radiographs

Fatty liver disease, caused by the accumulation of fat in the liver, is estimated to affect one in four people worldwide. If left untreated, it can lead to serious complications, such as cirrhosis and liver cancer, making it crucial to detect early and initiate treatment.

27 Jun 2025

Kennedy’s vaccine advisers sow doubts as scientists protest US pivot on shots

As fired and retired scientists rallied outside in the Atlanta heat, an advisory panel that Robert F. Kennedy Jr. handpicked to replace experts he'd fired earlier met inside the Centers for Disease Control and Prevention's headquarters to plan a more skeptical vaccine future.

27 Jun 2025

Ribosome biogenesis plays critical role in liver health and disease progression

This new review article highlights the critical role of ribosome biogenesis in liver health and disease progression.

25 Jun 2025

Alcoholic liver disease exacerbates HBV reactivation and worsens outcomes in liver transplant recipients

A recent study published in Engineering has shed light on the impact of alcoholic liver disease (ALD) on post-transplant hepatitis B virus (HBV) reactivation and survival outcomes in patients with hepatocellular carcinoma (HCC).

24 Jun 2025

Fructose consumption increases immune cell sensitivity to bacterial toxins

Despite medical advances, infectious diseases caused by bacteria and viruses are still among the most common causes of death worldwide.

24 Jun 2025

Transfer RNA-derived small RNAs transform the landscape of liquid biopsy

A new review highlights the transformative potential of transfer RNA-derived small RNAs (tsRNAs) in the field of liquid biopsy, emphasizing their role as promising biomarkers for a wide range of diseases, particularly cancers.

20 Jun 2025

Kupffer cell reprogramming in embryos explains metabolic disorders in offspring

Children born to obese mothers are at higher risk of developing metabolic disorders, even if they follow a healthy diet themselves.

18 Jun 2025

Mursla Bio introduces AI Precision Medicine Platform built on organ-specific EV isolation from blood

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly improve cancer outcomes for at-risk patients, today announced the commercial launch of its AI Precision Medicine Platform, alongside a pre-print reporting the first validated method for isolating hepatocyte EVs from plasma for organ-specific proteomic and miRNA profiling. Mursla Bio is engaging with potential partners to apply its Platform to additional disease areas, biomarker discovery and IV

17 Jun 2025

Fatty liver found in majority of type 2 diabetes patients

Six out of ten people with type 2 diabetes had fatty liver in a new study from Linköping University. Of these, only a small percentage had developed more severe liver disease.

17 Jun 2025